Arcticzymes Technologies ASA
OSE:AZT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tonkens Agrar AG
XETRA:GTK
|
DE |
Arcticzymes Technologies ASA
EPS (Diluted)
Arcticzymes Technologies ASA
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Arcticzymes Technologies ASA
OSE:AZT
|
EPS (Diluted)
kr0
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
Hofseth Biocare ASA
OSE:HBC
|
EPS (Diluted)
kr0
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
|
L
|
Lytix Biopharma AS
OSE:LYTIX
|
EPS (Diluted)
-kr1
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
EPS (Diluted)
$0
|
CAGR 3-Years
36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Circio Holding ASA
OSE:CRNA
|
EPS (Diluted)
kr0
|
CAGR 3-Years
82%
|
CAGR 5-Years
69%
|
CAGR 10-Years
49%
|
|
|
T
|
Thor Medical ASA
OSE:TRMED
|
EPS (Diluted)
kr0
|
CAGR 3-Years
67%
|
CAGR 5-Years
53%
|
CAGR 10-Years
26%
|
|
Arcticzymes Technologies ASA
Glance View
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.
See Also
What is Arcticzymes Technologies ASA's EPS (Diluted)?
EPS (Diluted)
0.2
NOK
Based on the financial report for Dec 31, 2025, Arcticzymes Technologies ASA's EPS (Diluted) amounts to 0.2 NOK.
What is Arcticzymes Technologies ASA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-35%
Over the last year, the EPS (Diluted) growth was 18%. The average annual EPS (Diluted) growth rates for Arcticzymes Technologies ASA have been -32% over the past three years , -35% over the past five years .
